Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810063 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Qiuling Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Natural and Biomimetic Medicine Research Center, Tissue-Orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School…. Hauptthemen laut MEDLINE: Hypertension, Renovascular, Network Pharmacology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sich…, the 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University, the Innovative Chinese Medicine Preclinical Research Fund of "Liqing No.2", West China Hospital, Sichuan University.
Abstract (Originalsprache)
Renovascular hypertension (RH), a secondary hypertension, can significantly impact heart health, resulting in heart damage and dysfunction, thereby elevating the risk of cardiovascular diseases. Coniferol (CA), which has vascular relaxation properties, is expected to be able to treat hypertension-related diseases. However, its potential effects on cardiac function after RH remain unclear. In this study, in combination with network pharmacology, the antihypertensive and cardioprotective effects of CA in a two-kidney, one-clip (2K1C) mice model and its ability to mitigate angiotensin II (Ang II)-induced hypertrophy in H9C2 cells were investigated. The findings revealed that CA effectively reduced blood pressure, myocardial tissue damage, and inflammation after RH. The possible targets of CA for RH treatment were screened by network pharmacology. The interleukin-17 (IL-17) and tumor necrosis factor (TNF) signaling pathways were identified using a Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The inflammatory response was identified using a Gene Ontology (GO) enrichment analysis. Western blot analysis confirmed that CA reduced the expression of IL-17, matrix metallopeptidase 9 (MMP9), cyclooxygenase 2 (COX2), and TNF α in heart tissues and the H9C2 cells. In summary, CA inhibited cardiac inflammation and fibrohypertrophy following RH. This effect was closely linked to the expression of MMP9/COX2/TNF α/IL-17. This study sheds light on the therapeutic potential of CA for treating RH-induced myocardial hypertrophy and provides insights into its underlying mechanisms, positioning CA as a promising candidate for future drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural and Biomimetic Medicine Research Center, Tissue-Orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610000,…
- Innovative Chinese Medicine Academician Workstation, West China Hospital, Sichuan University, Chengdu 610000, China.
Förderung
- the Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sich…
- the 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University
- the Innovative Chinese Medicine Preclinical Research Fund of "Liqing No.2", West China Hospital, Sichuan University
- Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sichuan…
- 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University
- Innovative Chinese Medicine Preclinical Research Fund of “Liqing No.2”, West China Hospital, Sichuan University
Zitieren
APA
Wu, Q., Zhou, Q., Wan, C., Xin, G., Wang, T., Gao, Y., Liu, T., Yu, X., Zhang, B., & Huang, W. (2024). Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810063
Vancouver
Wu Q, Zhou Q, Wan C, Xin G, Wang T, Gao Y, et al. Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810063
BibTeX
@article{Wu2024,
author = {Wu, Qiuling and Zhou, Qilong and Wan, Chengyu and Xin, Guang and Wang, Tao and Gao, Yu and Liu, Ting and Yu, Xiuxian and Zhang, Boli and Huang, Wen},
title = {Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810063}
}
EUVIMED